ReviewClinical immunology (Orlando, Fla.)2011

Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Neal N Padte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.